Cargando…
Expression of HPIP in epithelial ovarian carcinoma: a clinicopathological study
OBJECTIVES: Hematopoietic pre-B-cell leukemia transcription factor (PBX)-interacting protein (HPIP) plays an important role in cancer invasion and metastasis. The aim of this study is to investigate the expression of HPIP in epithelial ovarian cancer (EOC). PATIENTS AND METHODS: Immunohistochemical...
Autores principales: | Wang, Yuping, Meng, Fanling, Liu, Yunduo, Chen, Xiuwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5189975/ https://www.ncbi.nlm.nih.gov/pubmed/28053543 http://dx.doi.org/10.2147/OTT.S114884 |
Ejemplares similares
-
The clinical significance of HPIP and the associated prognosis in cervical cancer
por: Meng, Fanling, et al.
Publicado: (2017) -
Overexpression of HPIP as a biomarker for metastasis and prognosis prediction in endometrial cancer patients
por: Cheng, Li, et al.
Publicado: (2019) -
HPIP Silencing Prevents Epithelial–Mesenchymal Transition Induced by TGF-β1 in Human Ovarian Cancer Cells
por: Zhang, Guo-ying, et al.
Publicado: (2016) -
HPIP: a predictor of lymph node metastasis and poor survival in cervical cancer
por: Cao, Shan, et al.
Publicado: (2017) -
MicroRNA-595 sensitizes ovarian cancer cells to cisplatin by targeting ABCB1
por: Tian, Songyu, et al.
Publicado: (2016)